In many diagnostic applications it is favorable to use albumin as a blocking agent, bulking agent, stabilizer, or in other complimentary uses.InVitria's albumin for diagnostic applications outperforms BSA and pHSA, is chemically-defined, and is regulatory friendly.
Superior analyte stabilization
Lower cross-reactivity
Immunoglobulin free
Animal-free
Clinical Diagnostics Are Increasingly Precise - Get the Most Accurate Results Possible
You need accurate and consistent results.
But your reagents are not doing their job!
Get a new stabilizer and blocking agent that works as hard as you do for the best results.
Clinical diagnostics rely on sensitive techniques including antibody testing, immunoassays, or real-time PCR. Precision, accuracy, and consistency of results is vital in applications like:
Obtaining an accurate diagnosis
Monitoring a patient's response to therapy
Detecting small changes in a hormone or biomarker
With any common diagnostic immunoassay, these problems may arise:
Lack of specificity
Difficulty stabilizing a sensitive biomarker or protein
Cross reactivity and non-specific binding
An ineffective coating agent
Inconsistent or inaccurate results
The Real Problem
The main problem is the quality of the diagnostic stabilizer reagents used. Performance failure and inaccurate results usually result from:
Perishable reagents
Lack of chemical reagent consistency
Defective components
Poorly designed assay kits
Additional challenges arise as a result of the use of an animal or human-derived blocking agent such as BSA or human serum albumin from plasma. These include:
Occupational safety risks
Regulatory requirements due to animal components
Reagent IgG generating cross reactivity
Inconsistent results
Labeling guidelines for blood products
The Easy Solution
InVitria has designed diagnostic stabilizer reagents containing new recombinant albumin that specifically address these common problems.
Typical Assay Problems
Invitria Diagnostic Reagents
Lack of specificity
Significantly improve specificity
Cross reactivity and non-specific binding
Reduce non-specific binding and eliminate cross reactivity
Unstable protein or biomarker
Stabilize a sensitive protein or biomarker
Poor reagent consistency
Ensure better performance and consistent results
Variability in animal- and human-derived components
Outperform products such as BSA and human serum albumin from plasma
Occupational safety risk of using animal or human blood products
Eliminates occupational safety risk and regulatory concerns
Products from InVitria
Both Recombinant Albumin-DX and DX Lipid-Reduced:
Consistently enhance the stability of assay biomarkers
Improve antibody testing
Chemically-defined diagnostic stabilizer reagents
Make better blocking agents
Produce better results
Outperforming both BSA and human serum albumin from plasma
Better reagent contents
Better performance
Better results!
Eliminating animal and blood components in diagnostic stabilizer reagents is very beneficial:
Using BSA and human serum albumin involves strict regulations and compliance with occupational safety.
BSA is not an ideal or consistent blocking reagent. Sensitive techniques such as immunoassays or real-time PCR require consistency for precision.
How Invitria's Diagnostic Reagents Work
Recombinant Albumin-DX and DX Lipid-Reduced both contain a recombinant albumin produced in an animal component free production system.
It is highly purified, IgG-free and consistent, reducing non-specific binding and cross reactivity while maintaining the integrity of sensitive diagnostic biomarkers and proteins.
High performance - outperforms BSA, and other animal- and blood-derived products commonly used as diagnostic stabilizer reagents
Consistency - reproducible enhanced accuracy
Regulatory-friendly - eliminates safety risks and meets regulatory guidelines while improving diagnostic outcomes
Sensitive assays and diagnostic biomarker kits need a consistent stabilizing reagent that performs well. InVitria's products exceed these diagnostic needs.
